StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Pharma-Bio Serv's operating cash flow for the twelve months ending Jul 31, 2026 was -$414.89K. For fiscal 2025 it was -$214.89K. The highest annual figure on record is $5.63M in fiscal 2013.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Oct 31, 2025-$214.89K–
FY2024Oct 31, 2024-$566.70K-130.0%
FY2023Oct 31, 2023$1.89M+219.2%
FY2022Oct 31, 2022$592.46K-26.4%
FY2021Oct 31, 2021$804.84K-46.9%
FY2020Oct 31, 2020$1.51M–
FY2019Oct 31, 2019-$2.21M-159.4%
FY2018Oct 31, 2018$3.72M–
FY2017Oct 31, 2017-$922.67K-230.0%
FY2016Oct 31, 2016$709.65K+90.5%
FY2015Oct 31, 2015$372.61K-88.8%
FY2014Oct 31, 2014$3.33M-40.8%
FY2013Oct 31, 2013$5.63M+128.8%
FY2012Oct 31, 2012$2.46M+14.9%
FY2011Oct 31, 2011$2.14M+358.9%
FY2010Oct 31, 2010$466.35K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jul 31, 2026$60.89K-74.3%
Q2 FY2026CQ1 2026Apr 30, 2026-$365.31K–
Q1 FY2026CQ4 2025Jan 31, 2026-$390.14K–
Q4 FY2025CQ3 2025Oct 31, 2025$279.67K+256.6%
Q3 FY2025CQ2 2025Jul 31, 2025$236.52K–
Q2 FY2025CQ1 2025Apr 30, 2025-$301.59K–
Q1 FY2025CQ4 2024Jan 31, 2025-$429.49K-159.2%
Q4 FY2024CQ3 2024Oct 31, 2024$78.43K-74.6%
Q3 FY2024CQ2 2024Jul 31, 2024-$670.33K-170.1%
Q2 FY2024CQ1 2024Apr 30, 2024-$700.74K–
Q1 FY2024CQ4 2023Jan 31, 2024$725.95K-17.1%
Q4 FY2023CQ3 2023Oct 31, 2023$308.44K-7.2%
Q3 FY2023CQ2 2023Jul 31, 2023$956.77K–
Q2 FY2023CQ1 2023Apr 30, 2023-$250.11K-126.0%
Q1 FY2023CQ4 2022Jan 31, 2023$875.87K+98.3%
Q1 FY2022CQ4 2021Jul 31, 2022$332.37K–
Q2 FY2022CQ1 2022Apr 30, 2022-$1.11M-288.0%
Q4 FY2021CQ3 2021Oct 31, 2021$960.35K+185.5%
Q3 FY2021CQ2 2021Jul 31, 2021$441.72K-63.8%
Q2 FY2021CQ1 2021Apr 30, 2021-$1.19M–
Q1 FY2021CQ4 2020Jan 31, 2021$588.19K-61.2%
Q4 FY2020CQ3 2020Oct 31, 2020$336.37K–
Q3 FY2020CQ2 2020Jul 31, 2020$1.22M–
Q2 FY2020CQ1 2020Apr 30, 2020-$1.56M–
Q1 FY2020CQ4 2019Jan 31, 2020$1.52M–
Q4 FY2019CQ3 2019Oct 31, 2019-$539.81K-218.1%
Q3 FY2019CQ2 2019Jul 31, 2019-$627.30K-137.2%
Q2 FY2019CQ1 2019Apr 30, 2019-$822.92K-615.7%
Q1 FY2019CQ4 2018Jan 31, 2019-$217.71K-115.4%
Q4 FY2018CQ3 2018Oct 31, 2018$456.91K+63.4%
Q3 FY2018CQ2 2018Jul 31, 2018$1.69M–
Q2 FY2018CQ1 2018Apr 30, 2018$159.58K–
Q1 FY2018CQ4 2017Jan 31, 2018$1.42M+664.3%
Q4 FY2017CQ3 2017Oct 31, 2017$279.57K-39.6%
Q3 FY2017CQ2 2017Jul 31, 2017-$478.40K-1184.3%
Q2 FY2017CQ1 2017Apr 30, 2017-$909.23K–
Q1 FY2017CQ4 2016Jan 31, 2017$185.39K–
Q4 FY2016CQ3 2016Oct 31, 2016$463.24K–
Q3 FY2016CQ2 2016Jul 31, 2016$44.12K–

More Pharma-Bio Serv figures

See a number that looks wrong?